Abstract Introduction
G-150, all of which were obtained from Pharmacia Fine Chemicals, Piscataway, NJ. Hydroxylapatite (HTP) was obtained from Bio-Rad Laboratories, Richmond, CA; AcA 54 Ultragel from LKB Instruments (Bromma, Sweden or Rockville, MD). Polyacrylamide was obtained from Fisher Chemical Co., Norwood, OH. Synthetic chromogenic amides used as substrates in assays for enzymatic activities included S-2302 (Pro-Phe-Arg-paranitroaniline [PNA] ), S-2251 (Val-Leu-Lysparanitroaniline) and S-2160 (N-Benz.-Phe-Val-Arg-PNA), which were obtained from Kabi, Stockholm, Sweden, or Stamford, CT. CBZ-Ltyrosine-O-paranitroaniline was obtained from Sigma Chemical Co., St. Louis, MO. Na-BZ-Pro-Phe-Arg-PNA hydrochloride was obtained from Pentapharm, Basle, Switzerland. N-acetyl-L-tyrosine ethyl ester (ALTEE) was obtained from the Aldrich Chemical Co., Milwaukee, WI; soybean trypsin inhibitor from Worthington Chemical Corp., Freehold, NJ; streptokinase (SK) (high purity) from Lederle Laboratories, Pearl River, NY; benzamidine and L-lysine hydrochloride from Matheson, Coleman and Bell, Norwood, OH; sodium dodecyl sulfate (SDS) from Fisher Chemical Co., Norwood, OH; and BRIJ-35 from Calbiochem-Behring Corp., La Jolla, CA. Lysine-Sepharose was prepared using the instructions of the manufacturer for conjugating the lysine with Sepharose. Soybean trypsin inhibitor was similarly complexed with Sepharose.
Ellagic acid (4,4,5,5',6,6' hexahydroxydiphenic acid 2,6,2',6'-dilactone) used to activate Hageman factor was synthesized as described (4) . Stock solutions were prepared in barbital saline buffer, pH 7.4, by homogenization in a mechanical homogenizer and centrifuged at 15 ,000 g for 20 min. These solutions did not contain microscopically visible crystals. The barbital-saline buffer used in coagulation assays contained 2.06 g of sodium barbital, 2.76 g of barbital, and 7.8 g of sodium chloride in I liter of distilled water.
Plasmas were obtained from normal individuals and from persons with HANE associated with dysfunctional C1-INH protein previously characterized (3, 5) after informed consent was given by the donors. The plasmas were separated by plasmapheresis, and immediately mixed with benzamidine and disodium EDTA (see below).
Methods
Protein isolation. CI-INH was isolated from normal plasma by the procedure of Harrison (6, 7) , except that in some instances gel filtration on Sephacryl S-200 replaced that on Sephadex G-150. This provided CJ-INH, which was usually homogeneous in SDS gel electrophoresis, but in some preparations two closely approximated bands were seen (8) with as much as 70% recovery.
Plasma kallikrein. Plasma kallikrein was isolated by the method of Nagase and Barrett (9) , modified in that a second affinity step on SBTI-Sepharose was usually added after chromatography on Ultrogel AcA 54, and immune adsorption on a column of Sepharose-antihuman IgG was used when necessary. This kallikrein was homogeneous in SDS electrophoresis gels (Fig. 1) , and had specific activity as high as 235-446 U of coagulant activity (I U being the amount in 1.0 ml of pooled normal human plasma) per mg protein.
Human Hageman factor. Hageman factor was extracted from normal plasma using minor modifications of previously published procedures (10) (11) (12) . All test tubes and vessels were either coated with silicone (GE-Dri film, SC-87, Pierce Chemical Co., Rockford, IL) or made of polypropylene to prevent surface activation of Hageman factor. Blood was drawn into polypropylene bottles containing 1/50 of final volume of a solution of 0.5 M citrate buffer, pH 5.0, 0.1 M benzamidine hydrochloride, and 100 mg hexadimethrine bromide (Polybrene, Aldrich Chemical Co.) per 10 ml of solution. Plasma was rendered platelet deficient by recentrifugation of cell-free plasma at 12,000 g in a Sorvall RC-2B centrifuge for 20 min at 2°C. The Hageman factor was isolated by sequential chromatography upon columns of QAE-Sephadex A-50, DEAE Fig. 1 .
Plasminogen. Plasminogen was prepared by affinity chromatography according to the method of Deutsch and Mertz (13) . This material had a sp act of [17] [18] [19] [20] [21] CTA U/mg protein.
The plasminogen used in experiments testing the interactions with dysfunctional Cl-INH as analyzed on SDS-polyacrylamide gel electrophoresis (PAGE) containing a gradient of acrylamide concentrations (Fig. 4) Hageman factor and HFf were assayed in 5 mM Tris buffer, pH 7.8, using either S-2302 or Na-BZ-Pro-Phe-Arg-PNA HCI as a substrate.
Kallikrein. Kallikrein was assayed using the substrates and conditions described above for Hageman factor.
Plasmin. Plasmin was prepared by incubating, at room temperature and pH 7.4 for 10 min, three parts of plasminogen with one part of SK (1,000 U/ml). Its activity was measured with the substrate S-2251 in 0.05 M Tris, pH 7.4, containing 0.012 M sodium chloride.
For experiments on the interaction of dysfunctional Cl-INH with plasmin in SDS gels containing an acrylamide gradient, purified plasminogen was activated with purified SK as described by Remold-O'Donnell and Lewandrowski (17) Coagulation assays to quantify Hageman factor or kallikrein during fractionation were carried out by methods described (10) in which the correction of delayed clotting of a plasma of a person with a severe hereditary deficiency ofthe coagulation factor in question was measured. For these assays, column fractions were diluted 1:5 or 1:20 in either distilled water, or, when measuring Hageman factor, in barbital-saline buffer, pH 7.4, containing 1% bovine serum albumin. Fractions containing Hageman factor were added to a mixture of kaolin and Centrolex-O phospholipid in the presence of albumin or other protein.
Assays for Cli hydrolytic activity using the standard assay of Levy and Lepow (16) were performed in 0.067 M phosphate, pH 7.4, and the final acid released titrated in a microformol titration using a Radiometer automatic titrator and pH meter, model PHM 82, with a TTT 80 titrator and an ABU 80 autoburette (Radiometer, Copenhagen, Denmark).
SDS-polyacrylamide gradient gels were made by an adaptation of the method of Laemmli (18) . The gradient was 7.5 to 12.5% acrylamide prepared from stocks of 29.4% acrylamide and 0.6% bis-acrylamide.
Polymerization was initiated with ammonium persulfate and NNN,N'-tetramethyl-ethylene diamine (Eastman Kodak Co., Rochester, NY) at a final concentration of 0.036 and 0.017%, respectively. After polymerization of the gradient gel (usually within 50 min) of acrylamide and bis-acrylamide, a stacking gel of 3.5% acrylamide prepared from the same stock solution with identical concentrations of ammonium persulfate and NNN',N'-tetramethyl-ethylene diamine (Eastman Kodak Co.) was added. The gels were electrophoresed vertically at room temperature at 3-3.5 V/cm for 18 h or until the tracking dye was within 1-2 cm from the bottom of the gel. In this system Cli (M, = 87,000) and plasmin (M, = 77,000) migrated at about the same position corresponding to an -65,000-70,000 Mr. This system, however, was determined optimal for resolution of free inhibitor from complex and/or free enzyme and degradation products derived by apparent action of the proteases on the inhibitor. In standard 7.5 and 10% SDS-PAGE gels both proteases had molecular weights corresponding to previously reported values (13, 14) , and exhibited no evidence of degradation under any of those conditions (data not shown). The enzymes and inhibitors were incubated together at 37°C for 15 min, SDS added and incubation continued for 25 min before electrophoresis.
Results
Functional studies. As shown in Table II , purified dysfunctional C7-INH proteins exhibited a wide range of inhibitory activity against the enzymes tested. The different dysfunctional C7-INH proteins are indicated by the first two letters of each family name. With the exception of C7-INH Ri, all gave a significant degree of inhibition of Cli (19-90%) (Table II) using an esterolytic assay (ALTEE substrate). In an assay measuring Cli activity by esterolysis of CBZ-L-tyrosine-O-PNA, the depression of the hydrolytic rate of the C-is by the CI-INH proteins was in the range of l0-' to 10-' nmol of substrate hydrolyzed per minute per microgram inhibitor, but the inhibitor proteins depressed ALTEE hydrolysis by Cli from 6.7 to 100.5 nmol/min per Ag inhibitor. Although it appears that ALTEE is a more satisfactory substrate for determining the inhibition of Cli, it is possible that certain of the dysfunctional proteins block the hydrolysis of ALTEE more effectively than of CBZ-L-tyrosine-O-PNA. The levels of inhibition of preparations of C7 by infractionated serum samples from the patients studied are shown in column 2, Table II. Inhibition of the amidolytic properties of purified human plasma kallikrein by dysfunctional CI-INH proteins also varied widely compared to the activity of the normal C7-INH (Table  II) . Inhibition values ranged from 1% (Ri) to 64% (Za) of that provided by normal Ci-INH. There was a wide variation in visible complexes with the plasmin and there was no apparent cleavage of the inhibitor (Fig. 3, panel A, gels 3 and 4) . The preparation of CI-INH Ta contained two readily visible contaminants, the anodal of which was albumin (Fig. 3, not apparently cleaved by the enzyme (Fig. 3, (Fig. 4) . In these experiments, mixtures of Cli or plasmin and inhibitors were not boiled in SDS before being applied to the gels, and varied ratios of plasmin to inhibitor proteins were tested.
The interaction of normal CI-INH with Cls and plasmin is shown in Fig. 4 Harpel and Cooper (8) . CI-INH Ta formed a high molecular weight complex with ClIs when mixed at ratios of about 3:1 (Fig. 4 B, lane 3) (19) (Fig. 4 B, lanes 5 and 6). When CI-INH Ta and plasmin were mixed in approximately equimolar amounts (0.74:1), there appeared to be an increase in the formation of I', but the predominant species was a higher molecular weight complex (Fig. 4 B, (Fig. 4 C, lane 3) . When Cli and CI-INH We were present in equimolar amounts, no intact inhibitor remained, either in a complex or a proteolyzed form (Fig. 4 C,  lane 4) . Similarly with plasmin at a molar ratio of 23:1, inhibitor to enzyme, there appeared to be conversion to a lower molecular weight form (Fig. 4 C, lane 5) . At a molar ratio of 3:1 inhibitor to enzyme, the proteolysis of CI-INH
We by plasmin was very evident, as multiple bands were found probably ranging in molecular weight from 100,000 to -60,000
( Fig. 4 C, lane 6) . At 0.74:1 inhibitor to enzyme, all of the inhibitor was in the lower molecular weight form or was present as a higher molecular weight complex (Fig. 4 C, lane  7) . As previously noted (see Methods), it was difficult to obtain an accurate estimate of the molecular weight of the fragments because in the gradient gels the proteins used did not migrate according to their true molecular weight. CI-INH Ri formed a trace of a higher molecular weight complex when incubated with ClI at a molar ratio of 3:1 inhibitor to enzyme (Fig. 4 D, lane 3). CI-INH Ri appeared to be much more susceptible to limited proteolysis by plasmin, being completely converted to the I' form when incubated with plasmin at inhibitor to enzyme ratios of 3:1 and 0.74:1 (Fig. 4 D, lanes 5 and 6) . There appeared to be a small amount of a higher molecular weight complex at higher enzyme concentrations (poorly visible). C1-INH Za at threefold molar excess over ClI formed a small amount of complex with the Cls (Fig. 4 E, lane 3) . Addition of small amounts of plasmin led to proteolytic conversion of I to I' (Fig. 4 E, lane 4) . At 0.74:1 and 3:1 molar ratios of inhibitor to enzyme, no intact C1-INH Za remained, being completely converted to I' with a small amount of higher molecular weight complex remaining (Fig. 4 (Fig. 4 F, lane 3 ), but this dysfunctional inhibitor was rapidly degraded at all concentrations of plasmin (Fig. 4 F, lanes 4 to   6) . Apparently the complex of albumin with CI-INH Da is susceptible to plasmin proteolysis (Fig. 4 F, lanes 5 and 6) . At approximately equimolar amounts of C1-INH Da and plasmin there was a suggestion of formation of a high molecular weight complex. (Fig. 4 F, lanes 5 and 6) . (Fig. 4 D) .
CI-INH Ta also failed to form a visible complex with plasmin in the SDS disc gels (Fig. 3, panel B ) but complexes were visible under different experimental conditions (Fig. 4 B) (Fig.  4 , B and C). When conditions of electrophoresis were varied and graded concentrations of polyacrylamide were used in SDS gel studies (Fig. 4) , further information regarding the variability of the interactions of the dysfunctional proteins tested and plasmin and Cls were obtained, some of which was not evident in the SDS gels shown in Fig. 3 (Fig.  4) . Moreover, an I' fagment of CI-INH was generated in each of these mixtures except CI-INH We, as was seen with the normal Cl-INH as reported by Harpel and Cooper (8) . These gels were done with mixtures of enzymes and inhibitor were incubated in SDS and applied to graded polyacrylamide concentrations in gels without boiling, which may account for some of the additional detail not seen in Fig. 3 . It is clear that in several instances when sufficient plasmin was used, complexes can be formed with all dysfunctional CI-INH proteins tested in these gels, except Cl-INH Ri, as seen in Fig. 3 (panel A) (Fig. 4, panel F, lanes 5  and 6) .
Cl-INH Za was distinct in that it had an extraordinarily high activity against HFa, while its activities against Cli, plasmin and kallikrein were reduced. This enhanced activity against HFa is reminiscent of the altered function found in "antithrombin Pittsburgh" (26, 27) . Antithrombin Pittsburgh is an al proteinase inhibitor variant that acquired potent antithrombin activity because ofa single amino acid substitution of an arginine for a methionine (27) . This substitution was apparently sufficient to generate the potent antithrombin activity and induce a fatal hemorrhagic diathesis in the propositus (27) . It CI-INH Ta may also be susceptible to digestion by one or more serum proteases to which normal CI-INH is resistant, for the anti-Cls activity of Ci-INH Ta was lost when it was added to Ta serum, whereas that of the normal CI-INH was not. The in vivo behavior of three of the dysfunctional proteins described herein has been reported (5 
